An evidence based investigation into why people discontinue nicotinamide mononucleotide supplementation
Public attention to nicotinamide mononucleotide has grown quickly as evidence about NAD+ biology has entered mainstream discussion. Early animal data suggested broad benefits across metabolic and vascular systems, which helped move NMN from bench science to a consumer product. By 2024, the global market size was reported to be above 210 million US dollars, with […]